CCL20 and breast cancer: Kaplan-Meier survival analysis of GSE3494, GSE7390 and GSE26971 showed that metastasis-free survival (Fig. 3c) and overall survival (Fig. 3d) were decreased in the breast cancer patients with high CCL20 expression.